Research Article
Safety and Observations in a Pilot Study of Lenalidomide for Treatment in Autism
Table 4
Individual clinical global impression ratings over the 12-week study period.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Decreasing scores reflect increased improvement. values represent the results of the differences between baseline values and 6 and 12-month values using the Wilcoxon Signed Ranks Test. |